Comment: Telomeres in AD - The long and the short of it

Gregory A. Jicha

doi:10.1212/WNL.0b013e318247cce3

Comment: Telomeres in AD - The long and the short of it

Gregory A. Jicha

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	574
Number of pages	1
Journal	Neurology
Volume	78
Issue number	8
DOIs	https://doi.org/10.1212/WNL.0b013e318247cce3
State	Published - Feb 21 2012

Bibliographical note

Funding Information:
Disclosure: Dr. Jicha has received funding for travel or speaker honoraria from the Alzheimer Association; serves as a consultant for Pfizer Inc and Eli Lilly & Company; and receives research support from Pfizer Inc, Elan Corporation, Janssen, Medivation, Inc., Danone, and the NIH/NIA .

Funding

Disclosure: Dr. Jicha has received funding for travel or speaker honoraria from the Alzheimer Association; serves as a consultant for Pfizer Inc and Eli Lilly & Company; and receives research support from Pfizer Inc, Elan Corporation, Janssen, Medivation, Inc., Danone, and the NIH/NIA .

Funders
NIA/NIH
Pfizer Inc.
Elan Corporation

ASJC Scopus subject areas

Clinical Neurology

Access to Document

10.1212/WNL.0b013e318247cce3

Cite this

@article{17e95ba63d734a3f9cbc8cf2174e0af3,

title = "Comment: Telomeres in AD - The long and the short of it",

author = "Jicha, \{Gregory A.\}",

note = "Funding Information: Disclosure: Dr. Jicha has received funding for travel or speaker honoraria from the Alzheimer Association; serves as a consultant for Pfizer Inc and Eli Lilly \& Company; and receives research support from Pfizer Inc, Elan Corporation, Janssen, Medivation, Inc., Danone, and the NIH/NIA .",

year = "2012",

month = feb,

day = "21",

doi = "10.1212/WNL.0b013e318247cce3",

language = "English",

volume = "78",

pages = "574",

number = "8",

}

TY - JOUR

T1 - Comment

T2 - Telomeres in AD - The long and the short of it

AU - Jicha, Gregory A.

N1 - Funding Information: Disclosure: Dr. Jicha has received funding for travel or speaker honoraria from the Alzheimer Association; serves as a consultant for Pfizer Inc and Eli Lilly & Company; and receives research support from Pfizer Inc, Elan Corporation, Janssen, Medivation, Inc., Danone, and the NIH/NIA .

PY - 2012/2/21

Y1 - 2012/2/21

UR - https://www.scopus.com/pages/publications/84858139863

UR - https://www.scopus.com/pages/publications/84858139863#tab=citedBy

U2 - 10.1212/WNL.0b013e318247cce3

DO - 10.1212/WNL.0b013e318247cce3

M3 - Article

C2 - 22323752

AN - SCOPUS:84858139863

SN - 0028-3878

VL - 78

SP - 574

JO - Neurology

JF - Neurology

IS - 8

ER -

Comment: Telomeres in AD - The long and the short of it

Bibliographical note

Funding

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this